1. Home
  2. SELX vs ENLV Comparison

SELX vs ENLV Comparison

Compare SELX & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SELX

Semilux International Ltd. Ordinary Shares

HOLD

Current Price

$0.83

Market Cap

24.0M

Sector

N/A

ML Signal

HOLD

Logo Enlivex Therapeutics Ltd.

ENLV

Enlivex Therapeutics Ltd.

HOLD

Current Price

$0.82

Market Cap

26.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SELX
ENLV
Founded
2021
2005
Country
Taiwan
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
24.0M
26.6M
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
SELX
ENLV
Price
$0.83
$0.82
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$7.00
AVG Volume (30 Days)
192.3K
681.1K
Earning Date
05-15-2026
03-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,667,724.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
266.10
N/A
52 Week Low
$0.52
$0.66
52 Week High
$1.85
$2.10

Technical Indicators

Market Signals
Indicator
SELX
ENLV
Relative Strength Index (RSI) 57.04 46.43
Support Level $0.60 $0.66
Resistance Level $0.99 $0.88
Average True Range (ATR) 0.11 0.06
MACD 0.03 0.01
Stochastic Oscillator 63.06 74.75

Price Performance

Historical Comparison
SELX
ENLV

About SELX Semilux International Ltd. Ordinary Shares

Semilux International Ltd is a company that operates through its subsidiaries which is an optical and 3D sensing technology company that is involved in the customization, design and supply of optical components and integrated chip for various industries including autonomous driving, intelligent lighting, as well as unmanned aerial vehicles. In collaboration with its clients, TCO conceptualizes and produces high precision optics and sensing modules that are specifically customized to clients' needs for ease of integration in overall design and production. Applications for TCO's products include automotive laser headlight systems, adaptive driving beams (ADB) as well as light detection and autonomous driving systems (LiDAR).

About ENLV Enlivex Therapeutics Ltd.

Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.

Share on Social Networks: